Key result
Injection drug use is a significant risk factor for deep vein thrombosis, presenting with a complex clinical picture including coexisting infections and challenges in anticoagulant therapy adherence.
Why the study?
Venous thromboembolism carries a high risk of death or disability, and injection drug users represent a population at particular risk.
Case Report (n=5)
No
DVT in injection drug users is often complicated by severe local and systemic infections, requiring a holistic approach to anticoagulation, antibiotic therapy, and addiction management.
Alerts clinicians to VTE risk in injection drug users; hypothesis-generating and requires prospective studies before practice change.
Background Venous thromboembolism is the third most common cardiovascular disease and is associated with a high risk of death or disability. One group of patients at a particular risk of developing this disease are injection drug users. Case presentation A series of five cases of patients addicted to narcotic drugs, hospitalized at the Department of Angiology due to venous thromboembolism has been presented. The main risk factor was a venous or subcutaneous tissue injection of drugs. These cases reveal a complex clinical picture of venous thrombosis, difficulties in selecting and monitoring anticoagulant therapy, coexisting infections, as well as economic and psychosocial aspects. Conclusions Addiction to drugs administered by injection is a risk factor for venous thromboembolism, the clinical picture is complex and treatment is a major challenge for vascular medicine and drug addiction therapy. Education and preventive measures within the communities of drug addicts could be the most important actions aimed at reducing the incidence of deep vein thrombosis.
No takes yet. Share an insight, caveat, or question.
Fischer et al. (2022) conducted a case report in Deep vein thrombosis (n=5). Injection drug use was evaluated. Injection drug use is a significant risk factor for deep vein thrombosis, presenting with a complex clinical picture including coexisting infections and challenges in anticoagulant therapy adherence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: